Bard Associates Inc. Acquires 656,330 Shares of Modular Medical, Inc. (NASDAQ:MODD)

Bard Associates Inc. grew its holdings in shares of Modular Medical, Inc. (NASDAQ:MODD) by 81.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,462,930 shares of the company’s stock after buying an additional 656,330 shares during the quarter. Modular Medical makes up 1.1% of Bard Associates Inc.’s portfolio, making the stock its 25th largest position. Bard Associates Inc.’s holdings in Modular Medical were worth $3,292,000 as of its most recent SEC filing.

Separately, AWM Investment Company Inc. bought a new stake in Modular Medical during the first quarter worth about $1,388,000. 27.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Modular Medical

In other Modular Medical news, Director Philip Brent Sheibley bought 15,000 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were acquired at an average cost of $1.69 per share, with a total value of $25,350.00. Following the acquisition, the director now owns 66,139 shares of the company’s stock, valued at $111,774.91. The trade was a 29.33 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 32.34% of the company’s stock.

Modular Medical Stock Performance

MODD stock opened at $2.14 on Friday. Modular Medical, Inc. has a twelve month low of $1.00 and a twelve month high of $2.65. The business has a 50 day moving average price of $2.23 and a two-hundred day moving average price of $1.84.

Modular Medical (NASDAQ:MODD) last released its earnings results on Tuesday, August 13th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.08.

About Modular Medical

Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.